Navigation Links
Character Test for Australian Visa Subjective

nt, said the decision to revoke Haneef's visa "looks bad."

"Andrews' decision can be challenged on the grounds of bias or taking into account irrelevant considerations in making his decision -- this includes political considerations," he said.

Barns said he doubted Andrews' decision to cancel the visa could be considered "reasonable" -- the terminology required under the Migration Act.

"It looks as though the commonwealth has sought to get around their failure in Brisbane this morning to stop Haneef from getting bail, by using the Migration Act to achieve this end," he said.

"Andrews could have made a decision on Haneef when he was charged over the weekend - why wait until now?" he said.

"It is doubtful that Andrews' decision is reasonable as he suggests, given the weakness of the case against Haneef and that he is an innocent man," he said.

Senior University of New South Wales constitutional law lecturer Andrew Lynch also predicted Haneef would have a case to appeal against the decision.

He doubted the government was basing its decision on any extra information, saying police would have used all the evidence in their unsuccessful application for Haneef's bail to be refused.

The decision to cancel Haneef's visa seemed to be based on him being a relative of men implicated in the UK terrorism attacks, which was "unsatisfactory," he said.

And he rejected Andrews' assertions that the decision to cancel his visa was not prejudging Haneef's guilt or innocence.

"He's saying that Haneef's visa's cancelled because he's caught up in this, whereas the bail was granted because of a judicial finding that it wasn't," Lynch told Sky News.

However another newspaper has reported that Haneef had been in frequent and extensive contact with two men at the centre of Britain's car-bomb plot on the eve of
'"/>




Page: 1 2 3 4

Related medicine news :

1. Brain Enlargement May Be Characteristic of Autism
2. Symptoms In Dementia Patients Negatively Correlates With The Characteristics Of Caregivers
3. Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers
4. Doctors Confused by the Manly Characteristics of a Five-year-old Boy
5. Characteristics of Fast-Growing Skin Cancers
6. Both Alcohol and Neighborhood Characteristics can Affect Intimate Partner Violence
7. Australian Scientists Silence Cancer Gene
8. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
9. Australian Company Gets $10 million For Developing Skin Cancer Gel
10. Australian Health funds stand accused
11. Australian Court Finds Man Guilty of Spreading HIV/AIDS
Post Your Comments:
(Date:8/28/2008)... based in the Northeast region with more hires,pla...ARRISBURG, Pa., Aug. 28 /PRNewswire-USNewswire/ --...ed a Patient Safety Liaison for the,Northeast regi...e,Pennsylvania Patient Safety Reporting System (PA...izens., "Last year in focus groups with Pennsylva...
(Date:8/28/2008)...ke risk by 67%, but patients and doctors say drug ...(HealthDay News) -- Only 40 percent of patients wi...roke, who did suffer a stroke were taking the anti...mong those taking warfarin, 75 percent weren,t get...dditional 25 percent were taking medications that ...
(Date:8/28/2008)... Leading dermatology company serves growing prof... Palo Alto, CA (PRWEB) August 28, ...capital firm, today announced that together with M...is leading a Series A round of financing for Profe...tly invested $15.5 million in the round. Profex, a...
(Date:8/28/2008)...g. 28 /PRNewswire/ -- Guava Technologies, Inc.,ann...n Control Group to,provide drug discovery research...es. This non-exclusive agreement is a key componen...logies. The initiative is a direct,response to a v...ogy to,support higher throughput research in a com...
Breaking Medicine News(10 mins):Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 2Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 3
...owing evidence of a link between developing amyotr... Gehrig's disease and military service. This is a .... More research is needed as there have been very ...the disease and military service as mentioned in ...
...ation, or the Deutsche Forschungsgemeinschaft (DFG...enies access to new stem cell banks. In a stateme...n urgent need of revision.''Due to the key date re...d in the Stem Cell Act of 2002, German researchers...
...dmitted to Escorts Hospital and Research Centre he...condition //is "absolutely stable". "Mr. Pawar wa...is no problem other than stress and exhaustion. A ... his condition," Naresh Trehan, executive director...
... up their appointment for breast cancer screening ...ntment.// A report has shown that out of 79000 wo...ss than 60,000 women actually turned up for the ex...d of BreastCheck said 'It's an unusual service in ...
Other Medicine News:Health News:Link Shown Between Military Service And Risk For ALS 2Health News:Link Shown Between Military Service And Risk For ALS 3Health News:German Scientists Call For Review Of Stem Cell Act 2
(Date:8/26/2008)...- The Oregon Tourism Commission,launched its new f...Program,(Q Care) this week on http://www.OregonQC...eated to support the tourism and,hospitality indus...izing,the importance of quality customer service, ...esources to better serve Oregon,s visitors., "We,...
(Date:8/26/2008)...-- Semafore Pharmaceuticals Inc.,announced data pr...argeted,Therapies in Cancer in Washington, D.C., s...lar-targeted PI3 kinase (PI3K) inhibitor SF1126, b...part of a very powerful pathway, the PI3/AKT /mTOR...in cancer. Studies have shown that by,inhibiting t...
(Date:8/26/2008)... safely six weeks following surgical,treatment, R...Six weeks following,bunion surgery, most patients,...back behind the wheel of a car again. A study publ...one and Joint Surgery ( http://www.jbjs.org/ ),als...ents who underwent a,first metatarsal osteotomy (a...
(Date:8/26/2008)... -- Cambridge Research &,Instrumentation, Inc. (CR...Vivo Imaging System. The new system incorporates C...the entry-level instrument of choice for in,vivo f....com/cgi-bin/prnh/20080826/NETU054 ), FLEX techn...s unique,solid-state tunable optics that for the f...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Braking After Bunion Surgery 2Braking After Bunion Surgery 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 1Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 2Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City 8109 3INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 1INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 2INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 3INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 4INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 5INVEGA 28TM 29 Shows Favorable Long Term Safety Profile in a One Year Study of Patients With Schizophrenia 8107 6Network Health Awards Contract to HMS for Coordination of Benefits 8105 1Network Health Awards Contract to HMS for Coordination of Benefits 8105 2Kaiser Permanente to Host 30th Annual Diversity Conference 2152 1Kaiser Permanente to Host 30th Annual Diversity Conference 2152 2Kaiser Permanente to Host 30th Annual Diversity Conference 2152 3
... Safety and Single-Agent Activity Support Developm...Glioblastoma Multiforme, ROCKVILLE, Md., June 05, ...clinical-stage pharmaceutical company developing,t...matory diseases,announces the presentation of res... NCD (2ME2) in patients with glioblastoma,multifor...
... FLEMINGTON, N.J.--(BUSINESS WIRE)--Jun 5, 2007 - ...aceutical company developing,oral spray formulatio... announced that its two clinical studies comparing...t their primary,pharmacokinetic (PK), pharmacodyna...re currently marketed as Ambien(R), a leading,drug...
Other Medicine Technology:Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
...xtend is a three-part differential control assayed... J Series, T Series, AcT/AcT diff/AcT diff2, MD Se...1600, 1700, and 1800; ABX Micros 60; and Diatron A...n-vial stability of 30 days and a six-month closed...
From top to bottom, EZ STEER Bi-Directional Catheters put amazing responsiveness, predictability, and comfort close at hand. Utilizing a patented Biosense Webster micro-tensioning system that enables
... Auto is a whole blood control for evaluating the ...hat measure automated blood cell counts in patient...and WBC values for the Abbott CELL-DYN 3200, 4000 ... 2 and 3 only) and Sysmex XE-2100 instruments. Cel...
..., a whole blood assayed hematology control, offers...l differential available with the Coulter GENS, ST...pen-vial stability, 105-day closed-vial stability ...he 4.0ml pierceable cap vial is compatible with al...
Medicine Products: